LATEST NEWS

Mar 21, 2023

LIfT BioSciences announces breakthrough preclinical data demonstrating dual mode of action

LIfT BioSciences announces breakthrough preclinical data demonstrating the dual mode of action commonly believed necessary for curing solid

Feb 16, 2023

LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership

GMP N-LIfT being produced for forthcoming clinical trials LONDON, UK and MUNICH, Germany – February 16th, 2023. LIfT BioSciences, a...

Dec 19, 2022

LIfT BioSciences investors increase investment in LIfT and Johnson and Johnson welcomes LIfT into JL

London, 19 December 2022 – LIfT BioSciences is pleased to announce that it’s lead investor, Starbloom Capital, has provided further...